Company intelligence / Profile preview
H4 Orphan Pharma
Dijon, Bourgogne-Franche-Comté, Franceh4orphanpharma.com ↗
- Ownership
- Private
- Employees
- ~9
- Development stage
- Preclinical
01
Overview
H4 Orphan Pharma SAS is a French biotech/pharmaceutical SME founded in Dijon in 2016. The company specializes in developing small molecule drugs—specifically multifunctional ligands—for the treatment of orphan fibrotic diseases. Its two lead preclinical candidates target idiopathic pulmonary fibrosis and dry eye disease associated with Sjögren’s syndrome. Both compounds act via stimulation/modulation of the CFTR protein. The company owns its intellectual property outright and invests heavily in R&D (~83% of resources). In January 2025, it licensed an asset to TheraVet SA/EGEIRO Pharma for further development in idiopathic pulmonary fibrosis.
- Therapeutic areas
- OphthalmologyPulmonologyRare Diseases
- Modalities
- Small moleculesMultifunctional ligands
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
License agreement with TheraVet SA/EGEIRO Pharma for IPF program as part of a reverse takeover transaction valued at €14 million.Past exclusive merger negotiations with Cerenis Therapeutics were announced but not confirmed completed as of latest available data.
Beyond the preview
Go deeper on H4 Orphan Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on H4 Orphan Pharma.